Illumina, Inc. v. BGI Genomics Co., Ltd
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 ILLUMINA, INC., et al., Case No. 19-cv-03770-WHO
Plaintiffs,
ORDER RE MOTIONS FOR
v. PRELIMINARY INJUCTIONS
BGI GENOMICS CO., LTD, et al., Defendants.
Before me are two motions for a preliminary injunction filed by plaintiffs Illumina Inc. and Illumina Cambridge Ltd. (collectively, “Illumina”) in two related cases before me. Illumina contends that defendants BGI Genomics Co., Ltd., BGI Americas Corp., MGI Tech Co., Ltd., MGI Americas, Inc., and Complete Genomics, Inc. (collectively, “BGI”) infringe five of its patents related to DNA sequencing in two sets of its products. I find that Illumina has established a likelihood of infringement in both cases. Moreover, BGI has failed to identify significant questions as to the validity of Illumina’s patents, several of which have been challenged and found to be valid in the past. I further find that Illumina would suffer irreparable harm as a result of BGI’s infringing activities. For these…